Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...
from NDTV News - Latest https://ift.tt/36PjXS6
via
No comments:
Post a Comment